MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: Reversal by antipsychotic drugs

Journal of Neural Transmission

Volumn 119, Issue 6, 2012, Pages 661-667

  Seibt, Kelly Juliana ^a,b   Da Luz Oliveira, Renata ^a,b   Rosemberg, Denis Broock ^c,d   Savio, Luiz Eduardo Baggio ^c   Scherer, Emilene B S ^c   Schmitz, Felipe ^c   Wyse, Angela T S ^c   Bonan, Carla Denise ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional Translacional em Medicina (INCT TM)   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Inst Nacional de Ciência e Tecnologia em Excitotoxicidade e Neuroproteção   (Brazil)

Author keywords

Antipsychotics; DCF; K+ ATPase; MK 801; Na+; Schizophrenia; TBARS

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIZOCILPINE; HALOPERIDOL; OLANZAPINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SULPIRIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA; ZEBRA FISH;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FLUORESCEINS; HALOPERIDOL; LIPID PEROXIDATION; MALE; MEMBRANES; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SODIUM-POTASSIUM-EXCHANGING ATPASE; SULPIRIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ZEBRAFISH;

EID: 84863474488     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0745-z     Document Type: Article

References (60)

1. Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogutt S, Ozyurt H, Savaş HÁ (2002) The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 26:995-1005
2. Aperia A (2007) New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J Intern Med 261:44-52
3. Balijepalli S, Kenchappa RS, Boyd MR, Ravindranath V (2001) Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics. Neurochem Int 38:425-435
4. Barbazuk WB, Korf I, Kadavi C, Heyen J, Tate S, Wun E, Bedell JA, McPherson JD, Johnson SL (2000) The syntenic relationship of the zebrafish and human genomes. Genome Res 10:1351-1358
5. Barnes JM, Murphy PA, Kirkham D, Henley JM (1993) Interaction of guanine nucleotides with [3H]kainate and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain. J Neurochem 61:1685-1691
6. Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (2008) N-acetyl cysteine as a glutathione precursor for schizophrenia-A double-blind, randomized, placebo- controlled trial. Biol Psychiatry 64:361-368
7. Boison D, Singer P, Shen HY, Feldon J, Yee BK (2011) Adenosine hypothesis of schizophrenia-Opportunities for pharmacotherapy. Neuropharmacology (Epub ahead of print)
8. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:218-254
9. Cachat J, Stewart A, Grossman L, Gaikwad S, Kadri F, Chung KM, Wu N, Wong K, Roy S, Suciu C, Goodspeed J, Elegante M, Bartels B, Elkhayat S, Tien D, Tan J, Denmark A, Gilder T, Kyzar E, Dileo J, Frank K, Chang K, Utterback E, Hart P, Kalueff AV (2010) Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 5(11):1786-1799
10. Cadet JL, Lohr JB, Jeste DV (1987) Tardive dyskinesia and schizophrenic burnout: the possible involvement of cytotoxic free radicals. In: Henn FA, DeLisi LE (eds) Handbook of Schizophrenia: the neurochemistry and pharmacology of Schizophrenia. Amsterdam, Elsevier, pp 425-438
11. +-ATPase activities, antioxidant status and learning performance of aged rats. Pharmacol Res 48:245-251
12. +-ATPase in rat brain crude synaptosomes. Exp Gerontol 38:705-710
13. 2+-stimulated ATPase activity. Anal Biochem 157:375-380
14. Dencher NA, Frenzel M, Reifschneider NH, Sugawa M, Krause F (2007) Proteome alterations in rat mitochondria caused by aging, Ann. NY Acad Sci 1100:291-298
15. Dietrich-Muszalska A, Olas B (2007) Isoprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 4:1-6
16. Dietrich-Muszalska A, Olas B, Rabe-Jablonska J (2005) Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386-391
17. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH, Mohnot S, Beeson E, Glasgow E, Amri H, Zukowska Z, Kalueff AV (2009) Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 205(1): 38-44
18. Erecinska M, Cherian S, Silver IA (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol 73:397-445
19. Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann NY Acad Sci 1003:119-130
20. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L (2006) Oxidative stress involvement in schizophrenia pathophysiology. Encephale 32:244-252
21. Fenton WS, Hibbeln J, Knable M (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47:8-21
22. Gama CS, Salvador M, Andreazza AC, Lobato MI, Berk M, Kapczinski F, Belmonte-de-Abreu PS (2008) Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neurosci Lett 433(3):270-273
23. Gerlai R, Lahav M, Guo S, Rosenthal A (2000) Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67(4):773-782
24. Giacomini NJ, Rose B, Kobayashi K, Guo S (2006) Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 28:245-250
25. +-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 60:491-499
26. Grignon S, Chianetta JM (2007) Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations. Prog Neuropsychopharmacol Biol Psychiatry 31(2):365-369
27. + pump in epilepsy. Ann Neurol 16:S128-S134
28. Grossman L, Utterback E, Stewart A, Gaikwad S, Chung KM, Suciu C, Wong K, Elegante M, Elkhayat S, Tan J, Gilder T, Wu N, Dileo J, Cachat J, Kalueff AV (2010) Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 214(2):277-284
29. Jianfeng Yu, Dake Qi, Mengjuan Xing, Ruixi Li, Kaida Jiang, Yuwen Peng, Donghong Cui (2011) MK-801 induces schizophrenic behaviors through downregulating Wnt signaling pathways in male mice. Brain Res 1385:281-292
30. Kaplan JH (2002) Biochemistry of Na, K-ATPase. Annu Ver Biochem 71:511-535
31. Kokel D, Peterson RT (2008) Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 7(6):483-490
32. +-ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia-relationship to hemispheric dominance. Int J Neurosci 112:965-982
33. Lebel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 20,70-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227-231
34. Li JT, Su YA, Guo CM, Feng Y, Yang Y, Huang RH et al (2011) Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats. Eur J Pharmacol 652(1-3):65-72
35. Mahadik SP, Scheffer RE (1996) Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:45-54
36. Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11(6):851-876
37. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
38. Potts MB, Koh SE, Whetstone WD, Walker BA, Yoneyama T, Claus CP, Manvelyan HM, Noble-Haeusslein LJ (2006) Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx 3:143-153
39. Reddy RD, Yao JK (1996) Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55(1-2):33-43
40. Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, Jang S, Haggarty SJ, Kokel D, Rubin LL, Peterson RT, Schier AF (2010) Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327(5963):348-351
41. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52(1):139-153 Review
42. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H et al (2006) A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59:721-729
43. Rybakowski JK, Lehmann W (1994) Decreased activity of erythrocyte membrane ATPases in depression and schizophrenia. Biol Psychiatry 30:11-14
44. Seibt KJ, Oliveira Rda L, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G, Bonan CD (2010) Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav Brain Res 214(2):417-422
45. Siems WG, Hapner SJ, van Kuijk F (1996) 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase, Free Radic. Biol Med 20:215-223
46. Singh OP, Chakraborty I, Dasgupta A, Datta S (2008) A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia. Indian J Psychiatry 50(3):171-176
47. Stuchlík A, Petrásek T, Vales K (2009) Effect of alpha(1)-adrenergic antagonist prazosin on behavioral alterations induced by MK-801 in a spatial memory task in Long-Evans rats. Physiol Res 58:733-740
48. Swain HA, Sigstad C, Scalzo FM (2004) Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol 26:725-729
49. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem J 220(1):301-307
50. van Os J, Kapur S (2009) Schizophrenia. Lancet 374(9690):635-645
51. Vignini A, Nanetti L, Moroni C, Tanase L, Bartolini M, Luzzi S, Provinciali L, Mazzanti L (2007) Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites. Neurobiol Aging 28:987-994
52. Westerfield M (2007) The zebrafish book, 5th edn. University of Oregon Press, Eugene
53. +-ATPase in mouse brain synaptosomes. J Neurochem 52(4):1042-1049
54. +-ATPase activity after brain ischemia. Neurochem Res 25:969-973
55. Yao JK, Keshavan MS (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 15(7):2011-2035
56. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287-310
57. +-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death. Biochem Pharmacol 66:1601-1609
58. +-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats. Braz J Med Biol Res 34:1265-1269
59. Zhang M, Zhao Z, He L, Wan C (2010) A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci 53(1): 112-124
60. +-ATPase activity in an animal model of mania. J Neural Transm 116(4):431-436